Organon & Co.

OGN

6 Obserwujący

$9.03

+3.08%

$0.27

Obserwuj

5 Sierpień

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

OGN Fair Price

$71.50

Undervalued by 684.2%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Organon & Co. (OGN) is an international pharmaceutical company specializing in the research, development, and production of medicinal products and medical use products. The company focuses on a wide range of therapeutic areas, including women's health, neurology, cardiology, endocrinology, and others. Organon & Co. provides medicines and treatment options for patients with various health needs, contributes to the development of new drugs and innovative treatment procedures. The company emphasizes the high quality, safety, and effectiveness of its products and is dedicated to improving the health and quality of life of patients. Organon & Co. collaborates with medical professionals, research institutions, and healthcare organizations worldwide. Shares of Organon & Co. represent an intriguing investment opportunity for those who believe in the prospects of the pharmaceutical industry and its contributions to human health.

Feed

There are no posts to show right now.